C4 Therapeutics Inc
Biotechnology
Healthcare
CCCC
70.83 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.80
52 week high
7.00
high
2.83
52 week low
0.00
previous Close
2.61
P/E ratio
market cap
183 M
div yield
0
net profit margin
0.00 %
363.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top